Lumpkin named acting deputy commissioner at FDA
This article was originally published in Pharmaceutical Approvals Monthly
Executive SummaryMurray Lumpkin, MD, will be acting FDA deputy commissioner and oversee the new Office of International Programs as Senior Associate Commissioner for International Activities and Strategic Initiatives. Lumpkin previously headed FDA's Office of Review Management. The former Office of International and Constituent Affairs was split into the international component, which Lumpkin will lead, and the Office of Communications and Constituent Relations, which will be directed by Senior Associate Commissioner Linda Suydam
You may also be interested in...
Companies continue to throw their hats into the ring against the virus, with strategies ranging from ‘off the shelf’ molecules to novel vaccine and anti-viral therapies
Switzerland’s current economic and trading relationship with the UK is based on its MRA with the EU. So, where does this leave the two countries in trading with one another now each of their relationships with the EU are under threat?
The UK firm speaks about its efforts to tackle the virus as a recent spike in COVID-19 cases outside China heighten concerns.